AgeX Therapeutics' Unattributed VC Round

AgeX Therapeutics raised a round of funding on July 10, 2017.

AgeX Therapeutics develops BioTime technology relating to cell immortality and regenerative biology by developing products for the treatment of aging and age-related diseases.…

Articles about AgeX Therapeutics' Unattributed VC Round: